Press Releases for CRA

Press Releases
Celera and Aurora Enter Collaboration for Use of Cardiovascular Genetics
Celera Corporation Reports Second Quarter 2009 Results
Celera Presents Data Replicating Its Immunodiagnostic Assay to Detect Lung Cancer from Blood Serum
StreetInvesting.Com Free Research on WNR, BLL, CRA, AAV, ICO and NOV
Celera Announces Preliminary Second Quarter 2009 Revenue Results
BenchmarkJournal.Com Free Analyst Review for SYY, UHS, UNM, TCO, MIL and CRA
Celera Grants License to Bayer Schering Pharma for Cancer-Related Targets
Celera to Webcast Presentation at the Eighth Annual Needham Life Sciences Conference on June 11, 2009
Celera to Webcast Presentation at the Eighth Annual JMP Securities Research Conference on May 18, 2009
Celera Corporation Reports First Quarter 2009 Results
Celera Appoints H. Robert Superko, M.D., as Vice President, Chief of Medical Affairs
Celera Presents Results Showing That Carriers of an LPA Gene Variant Are at Elevated Risk of CHD Among Non-Users of Aspirin, but Not Among Aspirin Users
InforSense Used By Celera to Further Investigate Genetic Markers for Coronary Heart Disease
Celera Corporation First Quarter Fiscal 2009 Results and Conference Call Scheduled for May 6, 2009
deCODE and Celera Partner to Expand Use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
Celera Licenses Cardiovascular Biomarkers and Other Intellectual Property from Perlegen
Celera Presents Data Describing an Immunodiagnostic Assay to Detect Lung Cancer from Blood Serum
Celera Announces Chief Financial Officer Change
Celera and Collaborators Present Data Supporting the Suitability of a Prototype Fragile X Assay for Population Screening
Celera to Webcast Presentation as Part of the UBS West Coast Bus Tour on March 24, 2009
Celera and Collaborators Present Data Demonstrating the Association of Increased Risk for Heart Attack for Carriers with the KIF6 Gene Variant in a Hispanic Population from Costa Rica
Celera to Webcast Presentation at the Cowen Healthcare Conference on March 18, 2009
Zacks Analyst Blog Highlights: Celera, Brink's Home Security Holdings, Tyco International, General Motors Corp. And Advanced Micro Devices Inc.
Celera Corporation Reports Fourth Quarter Calendar 2008 Results
Celera Corporation Fourth Quarter Calendar 2008 Results and Conference Call Scheduled for February 17, 2009
Celera Announces the Appointment of K. Scott Bland as Vice President of Sales at Berkeley HeartLab
Celera to Webcast Presentation at JPMorgan Healthcare Conference
Celera and Abbott Revise Strategic Alliance from Profit Sharing to Worldwide Distribution and Royalty Agreements
Celera to Webcast Upcoming Financial Presentations
Celera Elects Wayne I. Roe to Board of Directors
Celera to Webcast Its Presentation at the Piper Jaffray Healthcare Conference
Celera and Abbott Enter Collaboration to Identify Pharmacogenomic Markers
Celera Appoints Scott K. Milsten as General Counsel
Celera Corporation Reports Third Quarter Calendar 2008 Results
NASDAQ OMX Announces Third Quarter 2008 New Listings Statistics
Celera Corporation Third Quarter Calendar 2008 Results and Conference Call Scheduled for October 28, 2008
Celera Appoints Christopher Hall as Chief Business Officer for Berkeley HeartLab
Celera to Webcast Presentation at Third Annual JMP Securities Healthcare Focus Conference
Brigham and Women's Hospital and Celera Publish Results Demonstrating That Carriers of a Variant of the LPA Gene Have More Than Two-Fold Higher Risk of Major Cardiovascular Events and That This Risk is Eliminated by Aspirin Therapy
Celera Corporation Files Its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission
Celera to Webcast Its Analyst and Investor Meeting on September 9, 2008
Celera Elects Peter Barton Hutt to Board of Directors
Celera Appoints Jean Amos Wilson, Ph.D., as Vice President of Laboratory Operations at Berkeley Heartlab
Celera Corporation Reports Fourth Quarter and Fiscal 2008 Results
FDA Grants Clearance for Celera's ViroSeq(R) HIV-1 Genotyping System Software v2.8
Celera Corporation Fourth Quarter and Fiscal 2008 Results and Conference Call Scheduled for July 23, 2008
NASDAQ OMX Welcomes Celera to The NASDAQ Stock Market
Celera Corporation (CRA) Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell
Celera Corporation Separates from Applera Corporation
Celera Corporation's Registration Statement Relating to the Separation of Celera from Applera Corporation Declared Effective by the S.E.C.
Celera to Webcast Presentation at Seventh Annual JMP Securities Research Conference - Jun 1 2008 4:43PM
Applera Corporation's Board of Directors Formally Approves Proposed Separation of Its Celera Business - Jun 1 2008 4:43PM
Celera Reports Third Quarter Fiscal 2008 Results
Celera to Webcast Presentation at Morgan Stanley Healthcare Conference
Applied Biosystems Group and Celera Group Third Quarter Fiscal 2008 Financial Results and Conference Call Scheduled for April 24, 2008
Celera Grants License to Merck & Co., Inc. for Cancer Targets